scienceneutral
E. coli ST410: How a Tiny Island Helps It Fight Antibiotics
GlobalMonday, April 13, 2026
E. coli strain ST410 is now a worldwide concern for clinicians, as it combines two powerful survival mechanisms that undermine antibiotic therapy.
Key Findings from a Large Genomic Survey
- Over 3,000 genomes were analyzed to trace the evolution of ST410.
- The majority of isolates harbor the blaNDM‑5 gene, conferring resistance to carbapenems—the last line of defense against many bacterial infections.
- A substantial proportion also carry a high‑pathogenicity island (HPI), a mobile DNA element that equips the bacteria to scavenge iron from their environment.
Experimental Insights
| Experiment | Observation |
|---|---|
| HPI‑positive vs. HPI‑negative strains | HPI‑positive bacteria absorbed iron more efficiently and grew faster under iron‑limited conditions. |
| Mouse infection models | Mice infected with HPI‑positive ST410 experienced more severe disease than those infected with strains lacking HPI. |
| Metallomics and enzyme assays | The presence of HPI increased intracellular zinc levels, enhancing the activity of the NDM‑5 enzyme. This synergy allowed ST410 to survive imipenem exposure both in vitro and in vivo. |
Why This Matters
The convergence of a metal‑acquisition system (HPI) and an antibiotic‑resistance determinant (blaNDM‑5) creates a robust pathogen that thrives under environmental pressures such as metal scarcity and antibiotic use. The study underscores how these selective forces shape the evolution of virulent bacterial clones across diverse settings, complicating treatment options and public health responses.
Actions
flag content
